Michael Sen and Helen Giza show confidence in Cordola's leadership for Care Delivery due to his extensive experience. They believe he'll be crucial for Fresenius Medical Care's ongoing transformation focusing on patient care.
The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars. Last week,$ノボ・ノルディスク(NVO.US)$presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Weight loss drugs lead the stock market As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market. $ノボ・ノルディスク(NVO.US)$, with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates. Meanwhile,$イーライリリー(LLY.US)$, whic...
Drugs used for weight loss like Ozempic pose a real risk to companies ranging from fast food restaurants to cigarette makers. Expect management teams of public companies to talk about them in their earnings calls. Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
MACRO Waller Says Fed 'Finally' Getting Good Inflation Data "In the last few months, we are finally getting very good inflation data that we wanted." Federal Reserve Governor Christopher Waller says at the annual E2 Summit in Park City, Utah. "If this continues, we're back to our target." U.S. Stocks Trade Mixed After Fed Minutes, Wholesale Inflation Data U.S. stocks were trading mixed Wednesday afternoon after the Federal ...
フレゼニウス・メディカル・ケアに関するコメント
コラムNovo Nordisk Sets New Record High: Analyzing the Market Effects of Popular GLP-1 Weight Loss Drugs
Last week, $ノボ・ノルディスク(NVO.US)$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Stock Markets Rocked as Weight Loss Sweeps the Globe
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$ノボ・ノルディスク(NVO.US)$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.
Meanwhile, $イーライリリー(LLY.US)$ , whic...
コラムOzempic, the Weight-Loss Drug, Steps Into Earnings Season Spotlight
Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
コラムWall Street Today | Waller Says Fed 'Finally' Getting Good Inflation Data
Waller Says Fed 'Finally' Getting Good Inflation Data
"In the last few months, we are finally getting very good inflation data that we wanted." Federal Reserve Governor Christopher Waller says at the annual E2 Summit in Park City, Utah. "If this continues, we're back to our target."
U.S. Stocks Trade Mixed After Fed Minutes, Wholesale Inflation Data
U.S. stocks were trading mixed Wednesday afternoon after the Federal ...
コラムUS Top Gap Ups and Downs on 8/14: X, SSL, HMC, NTR and More
Gap Ups
1. $USスチール(X.US)$ - up 23.4%
2. $ロイヤルフィリップス(PHG.US)$ - up 1.2%
3. $テレダイン・テクノロジーズ(TDY.US)$ - up 0.7%
Gap Downs
1. $サソル(SSL.US)$ - down 5.2%
2. $ヴァーレ(VALE.US)$ - down 4.8%
3. $フレゼニウス・メディカル・ケア(FMS.US)$ - down 4.0%
4. $本田技研工業(HMC.US)$ - down 2.5%
5. $ニュートリエン(NTR.US)$ - down 2...
コラムUS Top Gap Ups and Downs on 7/12: DPZ, JEF, NWG, ACHC and More
Gap Ups
1. $ドミノ・ピザ(DPZ.US)$ - up 8.7%
2. $ポスコ・ホールディングス(PKX.US)$ - up 5.2%
3. $フレゼニウス・メディカル・ケア(FMS.US)$ - up 4.6%
4. $ジェフリーズ・ファイナンシャル・グループ(JEF.US)$ - up 3.8%
5. $STマイクロエレクトロニクス(STM.US)$ - up 3.8%
6. $カンジュン(BZ.US)$ - up 3.8%
7. $ビリビリ(BILI.US)$ - up 3.7%
8. $リオ・ティント(RIO.US)$ - up 3....
コラムUS Top Gap Ups and Downs on 6/30: XPEV, NWG, LYG, ASX and More
Gap Ups
1. $シャオペン(XPEV.US)$ - up 4.2%
2. $ナットウエスト・グループ(NWG.US)$ - up 2.3%
3. $ロイズ・バンキング・グループ(LYG.US)$ - up 2.3%
4. $ノボ・ノルディスク(NVO.US)$ - up 2.2%
5. $コリア・エレクトリック・パワー(KEP.US)$ - up 2.1%
6. $バークレイズ(BCS.US)$ - up 1.6%
7. $ロイヤルフィリップス(PHG.US)$ - up 1.6%
8. $プルデンシャル(PUK.US)$ - up 1....
コラムUS Top Gap Ups and Downs on 6/28: XPEV, NFLX, PKX, BABA and More
Gap Ups
1. $ピンタレスト(PINS.US)$ - up 2.7%
2. $シャオペン(XPEV.US)$ - up 1.6%
3. $バンコ・サンタンデール(SAN.US)$ - up 1.4%
4. $フレゼニウス・メディカル・ケア(FMS.US)$ - up 1.4%
5. $野村ホールディングス(NMR.US)$ - up 1.3%
6. $トヨタ自動車(TM.US)$ - up 1.1%
7. $オリックス(IX.US)$ - up 0.7%
8. $本田技研工業(HMC.US)$ - up 0...
コラムUS Top Gap Ups and Downs on 6/27: U, SAN, WBA, ARGX and More
Gap Ups
1. $コリア・エレクトリック・パワー(KEP.US)$ - up 3.7%
2. $ユニティー・ソフトウェア(U.US)$ - up 2.9%
3. $ネットイーズ(NTES.US)$ - up 1.7%
4. $バンコ・サンタンデール(SAN.US)$ - up 1.5%
5. $ケロッグ(K.US)$ - up 1.5%
6. $サイア(SAIA.US)$ - up 0.9%
7. $プルデンシャル(PUK.US)$ - up 0.9%
8. $ロジテック・インターナショナル(LOGI.US)$ - up 0...
まだコメントはありません